经鼻湿化快速充气交换通气对创伤性脑损伤急诊手术全麻诱导期脑氧饱和度的影响
本前瞻性随机对照试验纳入2023年1—7月于苏北人民医院行颅内血肿清除术的创伤性脑损伤急诊全麻患者63例,随机分为常规面罩通气组(32例)与THRIVE组(31例)。预给氧10分钟时,THRIVE组手术侧与非手术侧rScO2均显著高于常规面罩通气组(手术侧:0.709±0.036 vs. 0.636±0.028,非手术侧:0.791±0.016 vs. 0.712±0.027,均P<0.01),PaO2显著升高、PaCO2显著降低,优势持续至插管成功后即刻。THRIVE组插管期低氧血症发生率显著降低[0%(0/31)vs. 28.12%(9/32),P<0.01],出院时GOS评分>3分的良好预后比例显著高于常规面罩通气组[35.5%(11/31)vs. 12.5%(4/32),P<0.05]。
要点
- 创伤性脑损伤急诊全麻诱导预给氧10分钟时,THRIVE组手术侧rScO2 0.709±0.036高于常规面罩通气组0.636±0.028(P<0.01)。
- THRIVE组插管期低氧血症(SpO2<0.95)发生率为0%(0/31),显著低于常规面罩通气组的28.12%(9/32)(P<0.01)。
- THRIVE组插管后首次机械通气PETCO2为43.10±2.66 mmHg,低于常规面罩通气组的49.22±3.31 mmHg(P<0.01)。
- THRIVE组出院时GOS评分>3分的良好预后比例为35.5%(11/31),高于常规面罩通气组的12.5%(4/32)(P<0.05)。
- 两组ICU住院天数和总住院天数无统计学显著差异(均P>0.05)。
适用人群与场景
- 2023年1—7月在苏北人民医院行颅内血肿清除术的创伤性脑损伤急诊全麻患者。
- 排除标准:术后死亡2例、无法配合闭口呼吸2例、胃窦超声图像获取不佳3例,均被排除。
诊断标准与关键阈值
- 低氧血症定义:脉搏氧饱和度(SpO2)<0.95。
- 良好预后定义:出院时格拉斯哥结局量表(GOS)评分>3分。
处置流程与药物剂量
- 常规面罩通气组:麻醉诱导前使用面罩无正压通气预给氧10分钟,氧流量8 L/min,吸入氧浓度(FiO2)1.00;麻醉诱导约90秒后,待肌松药起效(患者颌部肌肉松弛)行气管插管。
- THRIVE组:使用THRIVE预给氧10分钟,氧流量30 L/min,FiO2 1.00;麻醉诱导期间氧流量增至50 L/min并使用麻醉诱导药物,双手托下颌保持气道通畅,全程保持患者闭口;待肌松药起效(患者颌部肌肉松弛)后行气管插管。
研究设计与关键结果
- 研究类型:前瞻性随机对照试验;最终纳入63例,常规面罩通气组32例,THRIVE组31例。
- 两组性别、年龄、BMI、ASA分级、GCS评分、视神经鞘直径(ONSD)、基线生命体征、禁食情况、麻醉时间、手术时间及术中出血量均无统计学显著差异,具有可比性。
- 入手术室时,两组手术侧与非手术侧rScO2以及动脉血气指标PaO2、PaCO2均无统计学显著差异。
- 预给氧10分钟时,THRIVE组手术侧rScO2 0.709±0.036高于常规面罩通气组0.636±0.028,非手术侧rScO2 0.791±0.016高于常规面罩通气组0.712±0.027(均P<0.01)。
- 预给氧10分钟时,THRIVE组PaO2 450.23±60.99 mmHg高于常规面罩通气组264.88±49.33 mmHg(1 mmHg≈0.133 kPa,P<0.01),PaCO2 37.81±3.65 mmHg低于常规面罩通气组43.59±3.76 mmHg(P<0.01),且优势持续至插管成功后即刻。
- 两组超声检查各时间点胃窦横截面积(CSA)均无统计学显著差异。
- THRIVE组插管成功后首次机械通气时PETCO2 43.10±2.66 mmHg低于常规面罩通气组49.22±3.31 mmHg(P<0.01)。
- THRIVE组插管期低氧血症发生率为0%(0/31),常规面罩通气组为28.12%(9/32)(P<0.01)。
证据类型、等级与局限
- 证据类型:前瞻性随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,THRIVE可显著提高创伤性脑损伤急诊手术患者麻醉诱导期rScO2并改善其神经功能预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the effect of transnasal humidified rapid insufflation ventilatory exchange (THRIVE) on regional cerebral oxygen saturation (rScO2) during induction of general anesthesia in patients undergoing traumatic brain injury (TBI) emergency surgery.
METHODS: A prospective randomized controlled trial was conducted. The TBI emergency general anesthesia patients who underwent intracranial hematoma removal surgery at the Northern Jiangsu People's Hospital from January to July in 2023 were enrolled. The patients were divided into a conventional mask ventilation group and a THRIVE group using a random number table method. The patients in the conventional mask ventilation group were anesthetized and induced to pre oxygenate without positive pressure ventilation in the front mask for 10 minutes, with an oxygen flow rate of 8 L/min and an fraction of inspired oxygen (FiO2) of 1.00. After anesthesia induction for about 90 s, tracheal intubation was performed after the muscle relaxant took effect (patient's jaw muscle was relaxed). The patients in the THRIVE group were pre oxygenated with THRIVE for 10 minutes, with an oxygen flow rate of 30 L/min and a FiO2 of 1.00. During anesthesia induction, the oxygen flow rate was increased to 50 L/min, and anesthesia induction medication was used. The lower jaw of patient was supported with both hands to maintain airway patency, and the patient's mouth was kept closed throughout the process. After the muscle relaxant took effect (the patient's jaw muscle was relaxed), tracheal intubation was performed. At the time of patient entering the operating room, 10 minutes of pre oxygenation, and immediately after successful intubation, rScO2 was measured on the surgical and non-surgical sides. At the same time, ultrasound was used to measure the cross-sectional area (CSA) of the gastric antrum and arterial blood gas analysis was performed. The partial pressure of end-tidal carbon dioxide (PETCO2) during the first mechanical ventilation after successful tracheal intubation, the incidence of hypoxemia [pulse oxygen saturation (SpO2) < 0.95] during tracheal intubation, as well as prognostic indicators such as the length of intensive care unit (ICU) stay, total length of hospital stay, and Glasgow outcome scale (GOS) score at discharge were recorded.
RESULTS: During the study period, a total of 70 TBI patients underwent emergency general anesthesia surgery, of which 2 patients died postoperatively, 2 patients were unable to cooperate with closed mouth breathing, and 3 patients had poor ultrasound image acquisition in the gastric antrum, all of whom were excluded. A total of 63 patients were ultimately enrolled, including 32 in the conventional mask ventilation group and 31 in the THRIVE group. There were no statistically significant differences in gender, age, body mass index (BMI), American Society of Anesthesiologists (ASA) classification, Glasgow coma scale (GCS) score, optic nerve sheath diameter (ONSD), baseline vital signs, fasting situation, anesthesia time, surgical time, and intraoperative blood loss between the patients in the two groups, indicating comparability. When entering the operating room, there was no statistically significant difference in rScO2 on the surgical and non-surgical sides, and blood gas analysis indexes arterial partial pressure of oxygen (PaO2) and arterial partial pressure of carbon dioxide (PaCO2) between the patients in the two groups. When pre oxygenated for 10 minutes, both the surgical and non-surgical sides rScO2 levels in the THRIVE group were significantly higher than those in the conventional mask ventilation group (surgical side: 0.709±0.036 vs. 0.636±0.028, non-surgical side: 0.791±0.016 vs. 0.712±0.027, both P < 0.01), and the PaO2 was significantly increased [mmHg (1 mmHg ≈ 0.133 kPa): 450.23±60.99 vs. 264.88±49.33, P < 0.01], PaCO2 was significantly reduced (mmHg: 37.81±3.65 vs. 43.59±3.76, P < 0.01), and the advantage continues tilled immediately after successful intubation. There was no statistically significant difference in CSA at each time point of ultrasound examination between the two groups. Compared with the conventional mask ventilation group, the patients in the THRIVE group showed a significant decrease in PETCO2 during the first mechanical ventilation after successful tracheal intubation (mmHg: 43.10±2.66 vs. 49.22±3.31, P < 0.01), and the incidence of hypoxemia during tracheal intubation was also significantly reduced [0% (0/31) vs. 28.12% (9/32), P < 0.01]. In terms of prognostic indicators, there was no statistically significant difference in the length of ICU stay and total length of hospital stay between the patients in the conventional mask ventilation group and the THRIVE group [length of ICU stay (days): 10 (9, 10) vs. 10 (9, 11), total length of hospital stay (days): 28.00 (26.00, 28.75) vs. 28.00 (27.00, 29.00), both P > 0.05]. However, the proportion of patients in the THRIVE group with a good prognosis at discharge (GOS score > 3) was significantly higher than that in the conventional mask ventilation group [35.5% (11/31) vs. 12.5% (4/32), P < 0.05].
CONCLUSIONS: THRIVE can significantly increase rScO2 during anesthesia induction in TBI emergency surgery patients and improve their neurological function prognosis.
参考来源
- Zhao Y, Zhang Y, Huang T, et al. [Effect of transnasal humidified rapid insufflation ventilatory exchange on cerebral oxygen saturation during induction of general anesthesia in patients undergoing traumatic brain injury emergency surgery]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38813636. doi:10.3760/cma.j.cn121430-20230911-00774
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。